# Comparison of 129Xe MRI With 19F MRI in CF Lung Disease

> **NCT03482960** · EARLY_PHASE1 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 11 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Hyperpolarized Xenon gas
- **DRUG:** PFP

## Key facts

- **NCT ID:** NCT03482960
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-29
- **Primary completion:** 2019-04-09
- **Final completion:** 2019-04-10
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2021-01-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03482960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03482960, "Comparison of 129Xe MRI With 19F MRI in CF Lung Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03482960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*